Plasma biomarkers of immune regulation and senescence are associated with incident skeletal-related events in people with HIV: a case-cohort study
Persistent immune dysregulation in people with HIV (PWH) on antiretroviral therapy (ART) contributes to an increased risk of skeletal-related events (SREs), serving as a critical paradigm for understanding accelerated aging and age-related diseases. We investigated the association between plasma biomarkers of immune regulation and senescence with incident SRE risk and evaluated potential effect modification by sex. In a case-cohort study nested within the Spanish CoRIS cohort (65 incident SRE cases; 252 subcohort, including 5 overlapping cases), we quantified 24 baseline biomarkers of immune checkpoints and senescence-associated secretory phenotype factors. We estimated adjusted hazard ratios (aHR) using Borgan II-weighted cause-specific Cox regression models adjusted for clinical confounders (age, region of origin, prior AIDS diagnosis, CD4 + T-cell count, coinfections, and lifestyle factors). Sex-biomarker interactions were assessed as exploratory endpoints. Nineteen biomarkers were independently associated with increased SRE risk ( p < 0.05 & q < 0.10). Angiogenic factors (VEGF-A; aHR = 1.94; 95% CI, 1.40–2.68), immune checkpoints (PD-L2; aHR = 1.95; 95% CI, 1.09–3.49), and tissue remodeling markers (MMP-1; aHR = 1.91; 95% CI, 1.08–3.39) displayed independent associations, alongside consistent signals for TIM-3, PD-L1, and IL-8. Pairwise correlation analysis demonstrated clustering between checkpoints and inflammatory cytokines. Exploratory interaction analysis indicated that sex modified these associations; signals for seven markers (e.g., IL-1α, VEGF-A) were stronger in females, although the limited number of events warrants caution. Circulating biomarkers of immune exhaustion, inflammation, and senescence are independently associated with incident SREs in PWH on long-term ART. Our findings indicate a systemic pro-inflammatory signature and suggest that females exhibit higher sensitivity to inflammatory damage.
Authors
- Ana Virseda‐Berdices (ORCID: https://orcid.org/0000-0002-9549-567X)
- Rubén Martín‐Escolano (ORCID: https://orcid.org/0000-0002-6262-9344)
- Salvador Resino (ORCID: https://orcid.org/0000-0001-8783-0450)
- Rafael Rodrı́guez-Rosado
- Marta Rava (ORCID: https://orcid.org/0000-0003-2260-9370)
- María Ángeles Jiménez‐Sousa (ORCID: https://orcid.org/0000-0002-1945-6169)
- Carmen Elena Gómez Rodríguez
- Carlos Pita-Martínez
- Laura Gisbert Pérez
- CoRIS Cohort
- Álvaro Mena de Cea
- Santiago Moreno
- Carlos Armiñanzas
- Isidoro Martínez
Institutions
- Consejo Superior de Investigaciones Científicas (ES)
- Universidad de Alcalá (ES)
- Instituto de Salud Carlos III (ES)
- Centro Nacional de Microbiologia (ES)
- Centro Nacional de Epidemiología (ES)
- Centro Nacional de Biotecnología (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Centro de Investigación Biomédica en Red (ES)
- Mútua Terrassa (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Hospital Universitario Severo Ochoa (ES)
- Instituto de Investigación Biomédica de A Coruña (ES)
- Hospital Universitario Ramón y Cajal (ES)
Publication Details
- Journal
- Immunity & Ageing
- Published
- 2026-07-27
- DOI
- https://doi.org/10.1186/s12979-026-00583-7
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto de Salud Carlos III